ZBD: The approval notice for the listing application of fumaric acid lupatadine as a chemical raw material drug has been obtained
ZBD announced that its Jixi branch has received the approval notice for the marketing application of Fumaric Acid Lurasidone chemical raw materials issued by the National Medical Products Administration. Fumaric Acid Lurasidone is a long-acting antihistamine that acts on H1 receptors. The company has invested approximately RMB 6.6526 million in research and development expenses for this project
According to the Zhitong Finance APP, ZBD (603567.SH) announced that its Jixi branch recently received the "Approval Notice for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration, with the chemical raw material name: Fumaric Acid Lurasidone.
Fumaric Acid Lurasidone is a long-acting antihistamine that works by selectively antagonizing the H1 histamine receptor. As of now, the company has invested approximately RMB 6.6526 million in research and development expenses for the Fumaric Acid Lurasidone raw material project
